Tumour morphology and hormone receptor status are established predictors of breast cancer survival (Ruder et al, 1989; Northridge et al, 1997; Early Breast Cancer Trialists' Collaborative Group, 1998; Li et al, 2003). Here, NR4A1 is linked to breast cancer.